Malignant Peripheral Nerve Sheath Tumors (MPNST)

Oncology

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Malignant Peripheral Nerve Sheath Tumors (MPNST)?

There are 1 clinical trial targeting Malignant Peripheral Nerve Sheath Tumors (MPNST) tracked by BioSniper.

What is the prevalence of Malignant Peripheral Nerve Sheath Tumors (MPNST)?

The estimated prevalence of Malignant Peripheral Nerve Sheath Tumors (MPNST) is approximately 5.0 per 100,000 population.

Deep-dive into Malignant Peripheral Nerve Sheath Tumors (MPNST)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Malignant Peripheral Nerve Sheath Tumors (MPNST) — Drugs in Development & Clinical Trials | BioSniper